Today, Vertigenius™️ proudly announced a successful funding round, securing an impressive $2,100,000. Vertigenius™️ is at the forefront of merging technology with healthcare to combat vestibular disorders, ultimately enhancing balance and lessening dizziness. This revolutionary company offers a comprehensive system that encompasses a clinician portal, a patient app, and a wearable head sensor to streamline and democratize rehabilitation efforts. With this new funding, Vertigenius™️ plans to accelerate research and development to further refine their technology, expand their reach, and continue making positive strides in the treatment of vestibular disorders. The company's dedication to innovation and improving patient outcomes positions them as a key player in the intersection of healthcare and technology.
Vertigenius Secures $2.1M in Seed Funding to Revolutionize Vestibular Disorder Treatment
Recently funded · €2.1M SeedHealthcare
Get the full Vertigenius company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Aisot Technologies Switzerland | Seed | $2.5M | today |
| 2 |  DIMENSION United States | Seed | $1.6M | today |
